Bench-Scale Evaluation of Hydrothermal Processing Technology for Conversion of Wastewater Solids to Fuels
Hydrothermal Liquefaction (HTL) and Catalytic Hydrothermal Gasification (CHG) proof-of-concept bench-scale tests were performed to assess the potential of hydrothermal treatment for handling municipal wastewater sludge. HTL tests were conducted at 300 to 350 °C and 20 MPa on three different feeds:...
Veröffentlicht in: | Water environment research : a research publication of the Water Environment Federation. - 1998. - 90(2018), 4 vom: 01. Apr., Seite 329-342 |
---|---|
1. Verfasser: | |
Weitere Verfasser: | , , , , , , , |
Format: | Online-Aufsatz |
Sprache: | English |
Veröffentlicht: |
2018
|
Zugriff auf das übergeordnete Werk: | Water environment research : a research publication of the Water Environment Federation |
Schlagworte: | Journal Article Biofuels Sewage Waste Water Water 059QF0KO0R |
Zusammenfassung: | Hydrothermal Liquefaction (HTL) and Catalytic Hydrothermal Gasification (CHG) proof-of-concept bench-scale tests were performed to assess the potential of hydrothermal treatment for handling municipal wastewater sludge. HTL tests were conducted at 300 to 350 °C and 20 MPa on three different feeds: primary sludge, secondary sludge, and digested solids. Corresponding CHG tests were conducted at 350 °C and 20 MPa on the HTL aqueous phase output using a ruthenium-based catalyst. Biocrude yields ranged from 25 to 37%. Biocrude composition and quality were comparable to biocrudes generated from algae feeds. Subsequent hydrotreating of biocrude resulted in a product with comparable physical and chemical properties to crude oil. CHG product gas methane yields on a carbon basis ranged from 47 to 64%. Siloxane concentrations in the CHG product gas were below engine limits. The HTL-CHG process resulted in a chemical oxygen demand (COD) reduction of > 99.9% and a reduction in residual solids for disposal of 94 to 99% |
---|---|
Beschreibung: | Date Completed 18.10.2018 Date Revised 07.12.2022 published: Print Citation Status MEDLINE |
ISSN: | 1554-7531 |
DOI: | 10.2175/106143017X15131012152861 |